More than half of patients who stop GLP-1 weight-loss treatments are likely to restart them within a year, according to a study by the Endocrine Society. While many attempt to resume medications like Ozempic or Wegovy, research published in the Journal of Clinical Investigation Insight suggests that inconsistent dosing may reduce how effective these drugs … Read more
Patients diagnosed with Alzheimer’s disease who take glucosamine supplements face a 25% higher risk of death within five years compared to those who do not, according to a study published in Nature Metabolism by researchers at the University of Florida. The findings suggest that while the supplement may be safe for healthy brains, it potentially … Read more
As the conflict in Iran persists, the nation faces a severe humanitarian crisis marked by acute medicine shortages, soaring inflation, and a restrictive information environment. According to reports from NewsNation and data from the Iranian Human Pharmaceutical Industry Syndicate, the country’s pharmaceutical reserves are nearing depletion, with approximately 200 essential medical items currently in short … Read more
A government-commissioned study released Tuesday in the Journal of Studies on Alcohol and Drugs concludes that no level of alcohol consumption offers a protective health benefit, with risks of premature death and over 200 diseases rising even with one drink per day. The findings, originally commissioned under the Biden administration, were released independently after internal … Read more
Semaglutide might do more than manage weight; it could potentially slow biological aging. According to research from UC San Diego’s School of Medicine, the drug—marketed as Ozempic and Wegovy—showed the ability to slow the pace of biological aging by approximately 9% in a study of adults with HIV-associated lipohypertrophy. How does semaglutide impact biological aging? … Read more
The Future of Fiction: Why Human Embodiment Remains Our Greatest Literary Asset In an era where artificial intelligence can generate grammatically perfect prose in seconds, the literary world is undergoing a profound identity crisis. Author David Szalay, whose Booker Prize-winning novel Flesh explores the raw, physical reality of existence, recently noted a crucial distinction: AI … Read more
The Rise of the ‘Translated Era’: Why Non-English Narratives Are Dominating the Global Stage For decades, the English-speaking literary world operated as a fortress, with only a handful of “global” works managing to scale the walls. But the recent victory of Yáng Shuāng-zǐ and translator Lin King for Taiwan Travelogue marks more than just a … Read more
Neil Gaiman Case & The Shifting Sands of Accountability for Public Figures The recent dismissal of a lawsuit against author Neil Gaiman, stemming from allegations made by a former acquaintance, highlights a complex and evolving landscape surrounding accountability for public figures. While the Wisconsin court cited jurisdictional issues, the case – and Gaiman’s own admission … Read more
The Gaiman Allegations and a Looming Reckoning: Navigating Accountability in the Creative Industries The recent statement from Neil Gaiman denying allegations of sexual misconduct, surfacing over a year after initial claims, isn’t an isolated incident. It’s a stark illustration of a broader, ongoing struggle within the entertainment and creative industries: how to balance due process … Read more
The Future of Data Privacy: Beyond Compliance to Competitive Advantage The digital landscape is evolving at breakneck speed, and with it, the expectations surrounding data privacy. What was once a matter of legal compliance – exemplified by policies like GDPR and LOPDGDD – is rapidly becoming a core differentiator for businesses. Consumers are increasingly aware … Read more